Marshall Wace, LLP Ionis Pharmaceuticals Inc Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 1,920,464 shares of IONS stock, worth $68.4 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

1,920,464

Previous 173,199 1008.82%

Holding current value

$68.4 Million

Previous $8.25 Million 832.07%

% of portfolio

0.1%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$40.06 - $51.86 $70 Million - $90.6 Million	1,747,265 Added 1008.82%	1,920,464 $76.9 Million
Q2 2024 Aug 14, 2024	BUY	$36.45 - $47.7 $5.75 Million - $7.52 Million	157,756 Added 1021.54%	173,199 $8.25 Million
Q1 2024 May 15, 2024	SELL	$42.03 - $53.55 $4.96 Million - $6.32 Million	-118,106 Reduced 88.44%	15,443 $669,000
Q4 2023 Feb 14, 2024	BUY	$43.39 - $51.63 $2.84 Million - $3.38 Million	65,422 Added 96.03%	133,549 $6.76 Million
Q3 2023 Nov 14, 2023	SELL	$38.5 - $47.13 $36,036 - $44,113	-936 Reduced 1.36%	68,127 $3.09 Million
Q2 2023 Aug 14, 2023	BUY	$34.73 - $43.33 $2.4 Million - $2.99 Million	69,063 New	69,063 $2.83 Million
Q2 2021 Aug 13, 2021	BUY	$34.54 - $47.25 $6.11 Million - $8.35 Million	176,820 New	176,820 $7.05 Million
Q1 2021 May 17, 2021	SELL	$42.51 - $63.78 $4.73 Million - $7.1 Million	-111,269 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $2.46 Million - $3.28 Million	54,407 Added 95.68%	111,269 $6.29 Million
Q3 2020 Nov 16, 2020	BUY	$47.45 - $62.95 $2.7 Million - $3.58 Million	56,862 New	56,862 $2.7 Million
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $42,265 - $64,414	-1,016 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $24,501 - $29,697	455 Added 81.11%	1,016 $61,000
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $33,132 - $40,476	561 New	561 $34,000
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $2,794 - $3,876	-45 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$52.92 - $81.17 $2,381 - $3,652	45 New	45 $4,000
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $387,684 - $532,228	-8,939 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $383,304 - $480,024	8,939 New	8,939 $461,000

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.06B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Ionis Pharmaceuticals Inc Transaction History